Bank of America Cuts Humana (NYSE:HUM) Price Target to $260.00

Humana (NYSE:HUM) had its price target decreased by Bank of America from $320.00 to $260.00 in a report published on Tuesday,Benzinga reports. Bank of America currently has a neutral rating on the insurance provider’s stock.

Several other brokerages have also commented on HUM. Mizuho lifted their price target on shares of Humana from $305.00 to $316.00 and gave the stock an “outperform” rating in a research note on Wednesday, April 9th. Oppenheimer lifted their price objective on shares of Humana from $300.00 to $310.00 and gave the company an “outperform” rating in a research note on Thursday, May 1st. JPMorgan Chase & Co. dropped their price objective on shares of Humana from $257.00 to $256.00 and set a “neutral” rating on the stock in a research note on Tuesday, February 18th. Barclays set a $268.00 price objective on shares of Humana and gave the company an “equal weight” rating in a research note on Thursday, June 12th. Finally, Truist Financial set a $280.00 price objective on shares of Humana and gave the company a “hold” rating in a research note on Tuesday. Seventeen research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Humana has an average rating of “Hold” and an average target price of $280.76.

Humana Stock Performance

Shares of HUM stock opened at $243.60 on Tuesday. The company has a quick ratio of 1.91, a current ratio of 1.91 and a debt-to-equity ratio of 0.71. Humana has a 52 week low of $212.45 and a 52 week high of $406.46. The stock has a market capitalization of $29.40 billion, a PE ratio of 17.23, a P/E/G ratio of 1.84 and a beta of 0.43. The firm has a 50 day moving average of $246.87 and a two-hundred day moving average of $261.37.

Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $10.07 by $1.51. The business had revenue of $32.11 billion during the quarter, compared to analysts’ expectations of $32 billion. Humana had a net margin of 1.42% and a return on equity of 14.47%. The company’s revenue for the quarter was up 8.4% on a year-over-year basis. During the same period in the previous year, the company earned $7.23 EPS. On average, research analysts predict that Humana will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be issued a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 1.45%. The ex-dividend date is Friday, June 27th. Humana’s dividend payout ratio (DPR) is presently 25.04%.

Institutional Trading of Humana

Several institutional investors and hedge funds have recently modified their holdings of the business. Pinnacle Wealth Management Advisory Group LLC lifted its holdings in shares of Humana by 3.6% in the fourth quarter. Pinnacle Wealth Management Advisory Group LLC now owns 1,070 shares of the insurance provider’s stock valued at $272,000 after purchasing an additional 37 shares in the last quarter. Capital Advisors Ltd. LLC lifted its holdings in shares of Humana by 26.1% in the fourth quarter. Capital Advisors Ltd. LLC now owns 208 shares of the insurance provider’s stock valued at $53,000 after purchasing an additional 43 shares in the last quarter. Retirement Planning Co of New England Inc. lifted its holdings in shares of Humana by 4.7% in the fourth quarter. Retirement Planning Co of New England Inc. now owns 966 shares of the insurance provider’s stock valued at $245,000 after purchasing an additional 43 shares in the last quarter. LFA Lugano Financial Advisors SA lifted its holdings in shares of Humana by 56.3% in the fourth quarter. LFA Lugano Financial Advisors SA now owns 125 shares of the insurance provider’s stock valued at $32,000 after purchasing an additional 45 shares in the last quarter. Finally, Cary Street Partners Investment Advisory LLC lifted its holdings in shares of Humana by 63.9% in the first quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider’s stock valued at $31,000 after purchasing an additional 46 shares in the last quarter. Hedge funds and other institutional investors own 92.38% of the company’s stock.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.